Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats

Minimal hepatic encephalopathy is more common than the acute syndrome. Losartan, the first angiotensin-II receptor blocker (ARB), and candesartan, another widely-used ARB, have protected against developing fibrogenesis, but there is no clear data about their curative antifibrotic effects. The curren...

Full description

Bibliographic Details
Main Authors: H.A. Murad, Z.J. Gazzaz, S.S. Ali, M.S. Ibraheem
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2017-09-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017001100611&lng=en&tlng=en